tirzepatide phase 3 study results Improved Health-Related Quality of Life Compared with Insulin Lispro in Basal Insulin-Treated Adults with Type 2 Diabetes and Inadequate Glycaemic Control: A Randomised Controlled 3b Trial (SURPASS-6) 🚨 HOT OFF THE PRESS:

1 Euromonitor International, The GLP-1 revolution: insights for food and beverages, 2025 2 Innova Market Insights, The GLP-1 effect: redefining food, weight & health in the US, 2025 3 Euromonitor International, The GLP-1 revolution: insights for food and beverages, 2025 4 Chaston et al

R1500 Anti-ageing Solutions Wide variety of anti-ageing options available: Dermal filler-for volumisation of hollowed out areas and for enhancement and beautification eg lip filler

- : , ,

Erem F, Sontag-Strohm T, Certel M, Salovaara H, Loponen J: Functional characteristics of egg white proteins within wheat, rye, and germinated-rye sourdoughs

Drugs 23 FassettR

While PIONEER 6 demonstrated cardiovascular safety (non-inferiority), and the SOUL trial reported significant reductions in MACE, the oral formulation does not yet carry a formal FDA indication for cardiovascular risk reduction in high-risk adults with type 2 diabetes